A Bayesian tool for optimizing sample size in phase I dose-finding trials for head and neck cancer
The development of effective cancer treatments relies heavily on the successful execution of clinical trials, particularly Phase I trials, which are crucial for determining optimal drug dosages. In head and neck cancer, characterized by complex treatment needs and diverse patient responses, optimizi...
Saved in:
Main Author: | Sivakamavalli Jeyachandran |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Oral Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024003819 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AXL inhibition in treatment-resistant metastatic adenoid cystic carcinoma
by: Sivakamavalli Jeyachandran
Published: (2024-06-01) -
Novel therapy: Combined BRAF and MEK inhibitors for locally advanced BRAF V600L–Positive mucosal melanoma in hypopharynx
by: Sivakamavalli Jeyachandran
Published: (2024-06-01) -
Stereotactic body radiation therapy as initial treatment for head and neck cancer
by: Sivakamavalli Jeyachandran
Published: (2024-06-01) -
Advanced Monte Carlo for Acquisition Sampling in Bayesian Optimization
by: Javier Garcia-Barcos, et al.
Published: (2025-01-01) -
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocolsResearch in context
by: Moreno Ursino, et al.
Published: (2025-01-01)